RPB-32967-89625
2 vaccinations
1 coded response
15 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 433 / OH
- Registered
- 2022-01-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-12-05
Dose 1 — Moderna
-
2022-01-03
Dose 2 — Moderna
-
2022-01-04
Registered in v-safe
- 2022-01-04
- 2022-01-05
- 2022-01-06
- 2022-01-07
- 2022-01-08
- 2022-01-09
- 2022-01-10
- 2022-01-17
- 2022-01-24
- 2022-01-31
- 2022-02-07
- 2022-02-14
- 2022-04-04
- 2022-07-06
-
2023-01-03
Survey response — 12 months, dose 2MedDRA: Influenza — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-01-03
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-01-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-12-05 | Moderna | No |
| 2 | 2022-01-03 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release